Endonovo Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Endonovo Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4% to $140,242. The net income raised on $6,924,594 and profit margin reached 4938%. Total operating expenses were $2,404,934.
Profit Margin
| 2014 | 24.19K | -959.49K | -3966.16% |
|---|---|---|---|
| 2015 | 4.26K | -5.07M | -119087.95% |
| 2016 | 0 | -5.31M | |
| 2017 | 0 | -10.81M | |
| 2018 | 83.26K | -6.43M | -7729.53% |
| 2019 | 310.16K | -23.40M | -7545.93% |
| 2020 | 165.79K | -2.02M | -1222.32% |
| 2021 | 73.10K | -4.04M | -5535.13% |
| 2022 | 135.35K | -32.13M | -23743.85% |
| 2023 | 140.24K | 6.92M | 4937.6% |
ENDV Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 140.24K | 135.35K | 73.10K | 165.79K | 310.16K | 83.26K | 0 | 0 | 4.26K | 24.19K |
Cost of revenue | 654.75K | 9.99K | 14.98K | 65.36K | 93.38K | 12.93K | 14.76K | 0 | 2.16K | 15.48K |
Gross profit | -514.51K | 125.36K | 58.12K | 100.42K | 216.77K | 70.33K | -14.76K | 0 | 2.10K | 8.70K |
Operating exp. | ||||||||||
Research and development | 0 | 0 | 0 | 3.28K | 153.12K | 0 | 115.15K | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 2.40M | 3.38M | 2.28M | 3.01M | 4.02M | 4.22M | 4.60M | 5.41M | 2.50M | 2.19M |
Operating income | -2.91M | -3.26M | -2.22M | -2.91M | -3.80M | -4.15M | -4.60M | -5.41M | -2.49M | -2.19M |
Other income (expenses), net | 9.84M | -15.21M | -878.34K | 2.51M | -13.50M | 2.92M | -6.20M | 2.49M | -4.20M | 1.23M |
Income before tax | 6.92M | -18.47M | -3.10M | -395.58K | -17.31M | -6.43M | -10.81M | -5.31M | -5.07M | -959.49K |
Income tax expense | 0 | 13.66M | 941.56K | 1.63M | 6.09M | 2.92M | 6.20M | -95.25K | 2.58M | 1.58M |
Net income | 6.92M | -32.13M | -4.04M | -2.02M | -23.40M | -6.43M | -10.81M | -5.31M | -5.07M | -959.49K |
Earnings per share | ||||||||||
Basic EPS | 0.02 | -0.23 | -0.06 | -0.17 | -33.56 | -17.76 | -0.04 | -0.04 | -0.05 | -0.03 |
Diluted EPS | 0.00 | -0.23 | -0.06 | -0.17 | -33.56 | -17.76 | -0.04 | -0.04 | -0.05 | -0.03 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |